Reaction Details Report a problem with these data
Target
Histone H1.0
Ligand
BDBM35254
Substrate
n/a
Meas. Tech.
Binding Assay
Ki
2±0.0 nM
Citation
 Mates, S; Fienberg, A; Wennogle, L Methods and compositions for sleep disorders and other disorders US Patent  US8598119 Publication Date 12/3/2013 
Target
Name:
Histone H1.0
Synonyms:
H1-0 | H10_HUMAN | H1F0 | H1FV | Histone H1
Type:
Cell-surface receptors
Mol. Mass.:
20917.09
Organism:
Homo sapiens (Human)
Description:
P07305
Residue:
194
Sequence:
MTENSTSAPAAKPKRAKASKKSTDHPKYSDMIVAAIQAEKNRAGSSRQSIQKYIKSHYKVGENADSQIKLSIKRLVTTGVLKQTKGVGASGSFRLAKSDEPKKSVAFKKTKKEIKKVATPKKASKPKKAASKAPTKKPKATPVKKAKKKLAATPKKAKKPKTVKAKPVKASKPKKAKPVKPKAKSSAKRAGKKK
  
Inhibitor
Name:
BDBM35254
Synonyms:
2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine | CHEMBL715 | Olansek | US8802672, Olanzapine | Zyprexa | olanzapine
Type:
Small organic molecule
Emp. Form.:
C17H20N4S
Mol. Mass.:
312.432
SMILES:
CN1CCN(CC1)C1=Nc2ccccc2Nc2sc(C)cc12 |t:8|
Structure:
Search PDB for entries with ligand similarity: